IVMT-Rx-3 is a inhibitor of SDCBP targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin. IVMT-Rx-3 blocks MDA-9/Syntenin interaction with Src, reduces NF-kappaB activation, and inhibits MMP-2/MMP-9 expression. IVMT-Rx-3 inhibits Melanoma Metastasis[1]
Molecular Weight:
1542.52
Formula:
C69H90F3N13O24
Target:
MMP,NF-kappaB
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
